Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
Clinical trial NCT03925727 · COMPLETED
Trial details
- NCT number
- NCT03925727
- Sponsor
- Mimetogen Pharmaceuticals USA, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-28
- Primary completion
- 2020-06-11
- Enrollment
- 623
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.